Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices traded up today with the Dow Jones Industrial Average ( ^DJI) trading up 112 points (0.7%) at 16,695 as of Monday, May 12, 2014, 4:20 PM ET. The NYSE advances/declines ratio sits at 2,429 issues advancing vs. 632 declining with 133 unchanged. The Drugs industry as a whole closed the day up 2.1% versus the S&P 500, which was up 1.0%. Top gainers within the Drugs industry included Natural Alternatives International ( NAII), up 2.2%, XTL Biopharmaceuticals ( XTLB), up 4.9%, Reliv' International ( RELV), up 6.7%, EntreMed ( ENMD), up 2.4% and ProPhase Labs ( PRPH), up 4.6%. TheStreet Ratings Group would like to highlight 3 stocks pushing the industry higher today: EntreMed ( ENMD) is one of the companies that pushed the Drugs industry higher today. EntreMed was up $0.04 (2.4%) to $1.80 on light volume. Throughout the day, 8,596 shares of EntreMed exchanged hands as compared to its average daily volume of 22,100 shares. The stock ranged in a price between $1.71-$1.80 after having opened the day at $1.74 as compared to the previous trading day's close of $1.75. EntreMed has a market cap of $48.4 million and is part of the health care sector. Shares are up 5.0% year-to-date as of the close of trading on Friday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. Highlights from TheStreet Ratings analysis on ENMD go as follows: You can view the full analysis from the report here: EntreMed Ratings Report STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.